regular insulin

ApprovedSmall molecule

Sanofi

regular insulin is one of 286 small molecule programs targeting Stroke. It is currently in Approved.

Indications

Total Trials

Active Trials

285

Competitors

Pipeline

Status by Indication[3][1]

Indication

StrokeActive, not recruiting

Acute Coronary SyndromeActive, not recruiting

Type 2 Diabetes MellitusActive, not recruiting

Diabetes MellitusApproved

HyperglycemiaActive, not recruiting

Type 2 DiabetesActive, not recruiting

Type 1 DiabetesActive, not recruiting

Growth Hormone DeficiencyActive, not recruiting

CirrhosisActive, not recruiting

Spinal Cord InjuryActive, not recruiting

StrokePhase 3

Active, not recruiting

Acute Coronary SyndromeApproved

Active, not recruiting

Type 2 Diabetes MellitusApproved

Active, not recruiting

Diabetes MellitusApproved

Approved

HyperglycemiaApproved

Active, not recruiting

Type 2 DiabetesApproved

Active, not recruiting

Type 1 DiabetesPreclinical

Active, not recruiting

Growth Hormone DeficiencyPreclinical

Active, not recruiting

CirrhosisApproved

Active, not recruiting

Spinal Cord InjuryPhase 1

Active, not recruiting

Competition

Competitive Landscape

885 competitors in Type 2 Diabetes

#DrugCompanyPhaseTrials

regular insulin

Sanofi

Approved

1 2

Cysteine Hydrochloride

Novartis

Preclinical

1 3

Glargine

Eli Lilly

Preclinical

8 4

Inspra

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

2 5

Aurlumyn

BBTG International Inc.

Preclinical

1 6

Nexium

DDexcel Pharma Technologies Ltd.

Preclinical

1 7

Inderal

WWyeth-Lederle Vaccines

Preclinical

1 8

Cecon

MMcGuff Pharmaceuticals, Inc.

Preclinical

1 9

Forxiga

AstraZeneca

Preclinical

3 10

Lovaza

AstraZeneca

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 1Recruiting

Spinal Cord Injury

NCT07384052

Clinical

Trials by Indication[1]

Type 1 Diabetes2 trials

Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B

Completed·NNemours Children's Clinic·N/A·NCT00858273·41 enrolled

Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A

Completed·NNemours Children's Clinic·N/A·NCT00858897·10 enrolled

Efficacy and Safety1 trial

Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM

Completed·—·N/A·NCT01855243·63 enrolled

Diabetes Mellitus1 trial

Insulin in Treatment of Diabetes Mellitus With Pregnancy

Completed·—·N/A·NCT04726631·110 enrolled

Parenteral Nutrition1 trial

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Completed·KKing Faisal Specialist Hospital & Research Center·Phase 4·NCT02216799·61 enrolled

Hyperglycemia1 trial

Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery

Withdrawn·EEmory University·Phase 4·NCT01971047

14 more indications

Cirrhosis1 trial

Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial

Unknown status·—·Phase 4·NCT01143948·45 enrolled

Stem Cell Transplant1 trial

Glucose Control In Hematopoetic Stem Cell Transplant

Terminated·UUniversity of Oklahoma·N/A·NCT00582036·11 enrolled

Randomized1 trial

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Completed·XXeris Pharmaceuticals·Phase 2·NCT04074317·18 enrolled

Acute Coronary Syndrome1 trial

Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Suspended·—·Phase 4·NCT01151176·130 enrolled

Intensive Care Unit1 trial

Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit

Completed·UUniversity of Roma La Sapienza·Phase 4·NCT02165566·28 enrolled

Unknown status·NNational Taiwan University Hospital·Phase 3·NCT02607943·120 enrolled

Type 2 Diabetes Mellitus1 trial

Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.

Completed· Sanofi logo

Sanofi·Phase 4·NCT01122979·72 enrolled

Growth Hormone Deficiency1 trial

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

Unknown status·OOregon Health and Science University·N/A·NCT01804413·10 enrolled

Type 2 Diabetes1 trial

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery

Completed·EEmory University·Phase 4·NCT00596687·234 enrolled

Spinal Cord Injury1 trial

Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

Recruiting·HHealthPartners Institute·Phase 1·NCT07384052·12 enrolled

ESS1 trial

SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

Completed·UUniversity of Washington·Phase 2·NCT00438568·173 enrolled

Unspecified2 trials

Lyspro Insulin vs Regular Insulin in Cirrhotic Patients

Completed·UUniversity of Campania Luigi Vanvitelli·Phase 4·NCT00513201

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

Completed·BBecton, Dickinson and Company·Phase 2·NCT00553488·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 21 trial records for regular insulin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — regular insulin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for regular insulin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Sanofi

regular insulin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Trials by Indication[1]

Type 1 Diabetes2 trials

Efficacy and Safety1 trial

Diabetes Mellitus1 trial

Parenteral Nutrition1 trial

Hyperglycemia1 trial

Cirrhosis1 trial

Stem Cell Transplant1 trial

Randomized1 trial

Acute Coronary Syndrome1 trial

Intensive Care Unit1 trial

Effectiveness1 trial

After Cardiac Surgery1 trial

Stroke1 trial

Type 2 Diabetes Mellitus1 trial

Growth Hormone Deficiency1 trial

Type 2 Diabetes1 trial

Spinal Cord Injury1 trial

ESS1 trial

Unspecified2 trials

References

Drug Info

Quick Facts

Related News